Table 1: Baseline characteristics of study patients (N = 239).
Characteristic |
Amlodipine Group n = 121 |
Lisinopril Group n = 118 |
p-value |
Females, n (%) |
84 (69.4) |
71 (60.2) |
0.134 |
Age (years) |
60.7 ± 11.8 |
59.0 ± 12.1 |
0.270 |
Age groups (years), n (%) 18-39 40-54 55-64 ≥ 65 |
5 (4.1) 28 (23.1) 40 (33.1) 48 (39.7) |
5 (4.2) 36 (30.5) 43 (36.4) 34 (28.8) |
0.326 |
Marital status, n (%) Single Married Divorced/Widowed |
10 (8.3) 64 (52.9) 45 (38.1) |
10 (8.5) 63 (53.4) 45 (38.1) |
0.993 |
Occupation, n (%) Employed Business Unemployed |
12 (9.9) 35 (28.9) 74 (61.2) |
13 (11.0) 44 (37.3) 61 (51.7) |
0.320 |
Alcohol consumption, n (%) |
16 (13.2) |
13 (11.0) |
0.602 |
Smokers, n (%) |
7 (5.8) |
10 (8.5) |
0.419 |
Diabetics, n (%) |
15 (12.4) |
15 (12.7) |
0.941 |
History of heart failure, n (%) |
23 (19.0) |
19 (16.1) |
0.555 |
History of kidney failure, n (%) |
1 (0.8) |
5 (4.2) |
0.092 |
History of stroke, n (%) |
8 (6.6) |
6 (5.1) |
0.615 |
Body Mass Index (kg/m2) |
29.2 ± 6.2 |
28.2 ± 5.5 |
0.191 |
Obesity status, n (%) Normal weight Overweight Obese |
30 (25.0) 46 (38.3) 44 (36.7) |
40 (33.9) 43 (36.4) 35 (29.7) |
0.281 |
Waist circumference (cm) |
96 ± 12 |
94 ± 11 |
0.134 |
Central obesity, n (%) |
64 (52.9) |
56 (47.5) |
0.401 |
Baseline Systolic BP (mmHg) |
173 ± 19 |
169 ± 15 |
0.088 |
Baseline Diastolic BP (mmHg) |
101 ± 10 |
101 ± 11 |
0.992 |
Hypertension stage at baseline, n (%) Stage 2 Stage 3 |
78 (64.5) 43 (35.5) |
84 (71.2) 34 (28.8) |
0.266 |
Results are mean ± SD unless stated otherwise; p-values comparison between Amlodipine and Lisinopril treatment groups.